Nanobiotix S.A. RT-NBTXR3 followed by anti-PD-1 demonstrated favorable safety profile, disease control and tumor response in patients both naïve and resistant to anti-PD-1, suggesting that NBTXR3...
Pancreatic cancer is a formidable disease, often diagnosed too late for effective treatment. However, new research from the US-based Mayo Clinic represents a promising step towards...